Aindo
Generate evidence and insights from artificial data while maintaining privacy and security
- Also known as
- aindo
Available worldwide · Popular in: EU
What is Aindo?
A platform that uses generative AI to create synthetic datasets from real data, enabling healthcare organizations and researchers to conduct analysis, develop AI models, and run clinical trials while preserving patient privacy and regulatory compliance.
What Aindo does
The capabilities that matter for synthetic data, normalised so it lines up with every alternative. “-” means we haven't confirmed it, not that it's missing.
- Generation method
- LLM/transformer
- Relational integrity
- ✓
- Differential privacy
- -
- Privacy risk scoring
- -
- Fidelity utility reporting
- ✓
- Masking included
- -
- Deployment
- Both
- Open source
- -
- Ci cd integration
- -
- Industry focus
- Healthcare
- SOC2
- -
- HIPAA available
- -
- Pricing model
- Contact sales
Platform & deployment
Independently observed- Web
- Cloud / SaaS
- Self-hosted
Aindo alternatives
Other synthetic data we track, ranked by the same independent score.
- Tonic.aiGenerate synthetic data that mimics production patterns for testing and AI model trainingmedium · 56%
- K2viewUnified data platform that consolidates fragmented enterprise data sources and provides governed, real-time access with built-in compliancelow · 7%
- YData SyntheticAutomated platform for data profiling and privacy-compliant synthetic data generation at scalelow · 26%
- SynthoCreate realistic synthetic test data that protects privacy while maintaining production-like characteristicslow · 15%
- DataSynthesizerlow · 23%
- TSGMlow · 27%
The Vioscale score: one lens on the evidence
Not user reviews and not a paid placement: a confidence-weighted blend of the independent signals below (adoption, activity, security posture, and more), which you can sort and re-weight yourself. Vendors can correct their listing but can never move their rank, and stars are weighted low as a vanity metric. It is one way to read the evidence for Aindo, not the verdict.
| Signal | Score | Weight | Contribution | Evidence |
|---|---|---|---|---|
| Capabilities | 46 | 0.05 | 2.2 | ✓ |
| Security posture | 30 | 0.07 | 2.2 | ✓ |
| Price level | 0 | 0.05 | 0.0 | - |
| Reliability | 0 | 0.07 | 0.0 | - |
| Integrations | 0 | 0.04 | 0.0 | - |
| Pricing transparency | 0 | 0.08 | 0.0 | - |
Computed . Re-weight it by intent, or see the full method.
All data & sourcesshow ↓
Every value we hold, with its source, retrieval date, and confidence. This is the evidence behind the score: don't trust it, verify it.
Features
| Attribute | Value | Evidence |
|---|---|---|
| Capabilities | Deployment: both · Pricing model: contact-sales · Industry focus: healthcare · Generation method: LLM/transformer · Relational integrity: Yes · Fidelity utility reporting: Yes | mediumsource · 2026-08-21 · 60% |
Market
| Attribute | Value | Evidence |
|---|---|---|
| Availability | HqCountry: IT · PrimaryMarkets: … · AvailabilityScope: global · AvailableCountries: … · NotAvailableCountries: … | highsource · 2026-08-21 · 75% |